VANI Profitability Analysis: Past Growth, Margins, Return on Capital, Free Cash Flow, and more - Vivani Medical Inc - Alpha Spread

Vivani Medical Inc
NASDAQ:VANI

Watchlist Manager
Vivani Medical Inc Logo
Vivani Medical Inc
NASDAQ:VANI
Watchlist
Price: 1.23 USD 0.82% Market Closed
Market Cap: 67.6m USD
Have any thoughts about
Vivani Medical Inc?
Write Note

Profitability Summary

Vivani Medical Inc's profitability score is 27/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score
27/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Vivani Medical Inc

Revenue
0 USD
Operating Expenses
-25.3m USD
Operating Income
-25.3m USD
Other Expenses
1.1m USD
Net Income
-24.2m USD

Margins Comparison
Vivani Medical Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Vivani Medical Inc
NASDAQ:VANI
67.9m USD N/A N/A
US
Abbott Laboratories
NYSE:ABT
198.1B USD
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
174.1B USD
26%
28%
US
Stryker Corp
NYSE:SYK
138.7B USD
22%
16%
US
Boston Scientific Corp
NYSE:BSX
123.1B USD
18%
12%
IE
Medtronic PLC
NYSE:MDT
115.1B USD
19%
12%
US
Becton Dickinson and Co
NYSE:BDX
68B USD
15%
7%
DE
Siemens Healthineers AG
XETRA:SHL
55.5B EUR
12%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.6B USD
29%
22%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
41.3B USD
13%
8%
US
Edwards Lifesciences Corp
NYSE:EW
40.5B USD
28%
25%
Country US
Market Cap 67.9m USD
Operating Margin N/A
Net Margin N/A
Country US
Market Cap 198.1B USD
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 174.1B USD
Operating Margin
26%
Net Margin
28%
Country US
Market Cap 138.7B USD
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 123.1B USD
Operating Margin
18%
Net Margin
12%
Country IE
Market Cap 115.1B USD
Operating Margin
19%
Net Margin
12%
Country US
Market Cap 68B USD
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 55.5B EUR
Operating Margin
12%
Net Margin
8%
Country US
Market Cap 42.6B USD
Operating Margin
29%
Net Margin
22%
Country US
Market Cap 41.3B USD
Operating Margin
13%
Net Margin
8%
Country US
Market Cap 40.5B USD
Operating Margin
28%
Net Margin
25%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Vivani Medical Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Vivani Medical Inc
NASDAQ:VANI
67.9m USD
-86%
-45%
-53%
-106%
US
Abbott Laboratories
NYSE:ABT
198.1B USD
15%
8%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
174.1B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
138.7B USD
19%
9%
15%
11%
US
Boston Scientific Corp
NYSE:BSX
123.1B USD
9%
5%
9%
7%
IE
Medtronic PLC
NYSE:MDT
115.1B USD
8%
4%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
68B USD
5%
3%
6%
6%
DE
Siemens Healthineers AG
XETRA:SHL
55.5B EUR
11%
4%
8%
5%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.6B USD
63%
27%
51%
31%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
41.3B USD
21%
5%
10%
6%
US
Edwards Lifesciences Corp
NYSE:EW
40.5B USD
21%
15%
20%
21%
Country US
Market Cap 67.9m USD
ROE
-86%
ROA
-45%
ROCE
-53%
ROIC
-106%
Country US
Market Cap 198.1B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
9%
Country US
Market Cap 174.1B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 138.7B USD
ROE
19%
ROA
9%
ROCE
15%
ROIC
11%
Country US
Market Cap 123.1B USD
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country IE
Market Cap 115.1B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 68B USD
ROE
5%
ROA
3%
ROCE
6%
ROIC
6%
Country DE
Market Cap 55.5B EUR
ROE
11%
ROA
4%
ROCE
8%
ROIC
5%
Country US
Market Cap 42.6B USD
ROE
63%
ROA
27%
ROCE
51%
ROIC
31%
Country US
Market Cap 41.3B USD
ROE
21%
ROA
5%
ROCE
10%
ROIC
6%
Country US
Market Cap 40.5B USD
ROE
21%
ROA
15%
ROCE
20%
ROIC
21%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top